Active Pharmaceutical Ingredients CDMO Market Historical Data & Forecasts By 2028
Active Pharmaceutical Ingredients CDMO Industry Overview The global active pharmaceutical ingredients CDMO market size is expected to reach USD 136.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. Increasing pharmaceutical R&D investment, patent expirations, and rise in demand for generic drugs and biologic innovation are the factors driving the market. Active Pharmaceutical Ingredients CDMO Market Segmentation Grand View Research has segmented the global active pharmaceutical ingredients CDMO market based on product, synthesis, drugs, application, workflow, and region: Based on the Product Insights, the market is segmented into Traditional Active Pharmaceutical Ingredient, Highly Potent Active Pharmaceutical Ingredient, Antibody Drug Conjugate (ADC), Others. The traditional active pharmaceutical ingredient segment dominated the market and accounted for the largest reven...